Women Of Color Receive Slower Response To A Bad Mammogram

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 19, 2025.

By Dennis Thompson HealthDay Reporter

WEDNESDAY, Feb. 19, 2025 -- Women of color are less likely to receive prompt follow-up testing after abnormal mammogram results, a new study has found.

Minority women are less likely than white women to receive a same-day advanced imaging or biopsy after an abnormal mammogram, even though they have similar access to those services, researchers reported.

Black women were 44% less likely than white patients to receive same-day follow-up, while Hispanic women were 39% less likely and Asian women 26% less likely.

This racial disparity is undoubtedly causing many women undue fear and anxiety, said lead researcher Dr. Marissa Lawson, an assistant professor of radiology at the University of Washington School of Medicine in Seattle.

“Getting a screening mammogram is an anxiety-inducing experience for a lot of people, and most patients I encounter want their results as soon as possible,” Lawson said in a news release.

“If you're able to do a diagnostic workup on the same day, instead of making them wait to schedule a follow-up visit -- which might create a headache with work or transportation -- that’s better for the patient,” she continued.

Follow-up testing after an abnormal mammogram could involve a more intensive mammogram, a breast MRI or an ultrasound scan, according to the National Cancer Institute. If those tests confirm the abnormal results, then a biopsy is needed.

For the new study, researchers analyzed the records of more than 1.1 million women between 40 and 89 years of age who underwent screening mammography at 136 facilities across six U.S. states between 2010 and 2020.

The research team did not find major differences in onsite availability of advanced imaging and biopsy services for women from different racial or economic backgrounds.

“It was surprising to find similar availability (of technologies) across racial and ethnic groups,” Lawson said. “But we still saw big differences in who was getting those same-day services.”

For example, patients who lived in the lowest-income neighborhoods were 58% less likely to receive same-day follow-up, researchers noted.

Black women also faced a lag in receiving a same-day biopsy if a follow-up scan confirmed abnormal mammogram findings, results show. They were 54% less likely to get a prompt biopsy.

Researchers noted that women living in rural areas were 51% more likely to receive same-day follow-up than urban dwellers.

“The finding that rural individuals receive more same-day services suggests that services may be targeted to patients with clear barriers such as long travel times,” the research team wrote.

The new study was published Feb. 18 in the journal Radiology.

Sources

  • University of Washington, news release, Feb. 18, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-02-20 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords